Marinus Pharmaceuticals Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
166
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
10
Marinus Pharmaceuticals General Information
Description
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
Contact Information
Website
www.marinuspharma.com(Operating Subsidiary)
Corporate Office
- 5 Radnor Corporate Center, 100 Matsonford Road
- Suite 500
- Radnor, PA 19087
- United States
Corporate Office
- 5 Radnor Corporate Center, 100 Matsonford Road
- Suite 500
- Radnor, PA 19087
- United States
Marinus Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Marinus Pharmaceuticals Comparisons
Industry
Financing
Details
Marinus Pharmaceuticals Competitors (58)
One of Marinus Pharmaceuticals’s 58 competitors is Alnylam Pharmaceuticals, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| ACADIA Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Aclaris Therapeutics | Formerly VC-backed | Wayne, PA |
Marinus Pharmaceuticals Signals
Marinus Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Marinus Pharmaceuticals FAQs
-
When was Marinus Pharmaceuticals founded?
Marinus Pharmaceuticals was founded in 2003.
-
Where is Marinus Pharmaceuticals headquartered?
Marinus Pharmaceuticals is headquartered in Radnor, PA.
-
What is the size of Marinus Pharmaceuticals?
Marinus Pharmaceuticals has 166 total employees.
-
What industry is Marinus Pharmaceuticals in?
Marinus Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Marinus Pharmaceuticals a private or public company?
Marinus Pharmaceuticals is a Private company.
-
What is the current valuation of Marinus Pharmaceuticals?
The current valuation of Marinus Pharmaceuticals is .
-
What is Marinus Pharmaceuticals’s current revenue?
The current revenue for Marinus Pharmaceuticals is .
-
How much funding has Marinus Pharmaceuticals raised over time?
Marinus Pharmaceuticals has raised $217M.
-
Who are Marinus Pharmaceuticals’s investors?
Avoro Capital, Bain Capital Life Sciences, Canaan Partners, Connecticut Innovations, and Domain Associates are 5 of 14 investors who have invested in Marinus Pharmaceuticals.
-
Who are Marinus Pharmaceuticals’s competitors?
Alnylam Pharmaceuticals, ACADIA Pharmaceuticals, Vertex Pharmaceuticals, Sarepta Therapeutics, and Aclaris Therapeutics are some of the 58 competitors of Marinus Pharmaceuticals.
-
When was Marinus Pharmaceuticals acquired?
Marinus Pharmaceuticals was acquired on 07-Feb-2025.
-
Who acquired Marinus Pharmaceuticals?
Marinus Pharmaceuticals was acquired by Immedica Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process